JP2009504761A5 - - Google Patents

Download PDF

Info

Publication number
JP2009504761A5
JP2009504761A5 JP2008527115A JP2008527115A JP2009504761A5 JP 2009504761 A5 JP2009504761 A5 JP 2009504761A5 JP 2008527115 A JP2008527115 A JP 2008527115A JP 2008527115 A JP2008527115 A JP 2008527115A JP 2009504761 A5 JP2009504761 A5 JP 2009504761A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
formula
heteroaryl
short
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008527115A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009504761A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/032027 external-priority patent/WO2007024600A2/en
Publication of JP2009504761A publication Critical patent/JP2009504761A/ja
Publication of JP2009504761A5 publication Critical patent/JP2009504761A5/ja
Pending legal-status Critical Current

Links

JP2008527115A 2005-08-19 2006-08-16 睡眠剤と置換ビスアリール及びヘテロアリール化合物の組み合わせ物及び治療でのその使用 Pending JP2009504761A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70965505P 2005-08-19 2005-08-19
PCT/US2006/032027 WO2007024600A2 (en) 2005-08-19 2006-08-16 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof

Publications (2)

Publication Number Publication Date
JP2009504761A JP2009504761A (ja) 2009-02-05
JP2009504761A5 true JP2009504761A5 (cg-RX-API-DMAC7.html) 2009-09-24

Family

ID=37772166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008527115A Pending JP2009504761A (ja) 2005-08-19 2006-08-16 睡眠剤と置換ビスアリール及びヘテロアリール化合物の組み合わせ物及び治療でのその使用

Country Status (17)

Country Link
US (1) US7618650B2 (cg-RX-API-DMAC7.html)
EP (1) EP1928442B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009504761A (cg-RX-API-DMAC7.html)
KR (1) KR20080038416A (cg-RX-API-DMAC7.html)
CN (1) CN101242819A (cg-RX-API-DMAC7.html)
AR (1) AR055609A1 (cg-RX-API-DMAC7.html)
AT (1) ATE447400T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006283703A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0614943A2 (cg-RX-API-DMAC7.html)
CA (1) CA2617980A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006010219D1 (cg-RX-API-DMAC7.html)
ES (1) ES2336142T3 (cg-RX-API-DMAC7.html)
MX (1) MX2008001778A (cg-RX-API-DMAC7.html)
RU (1) RU2008110498A (cg-RX-API-DMAC7.html)
SG (1) SG140147A1 (cg-RX-API-DMAC7.html)
TW (1) TW200815009A (cg-RX-API-DMAC7.html)
WO (1) WO2007024600A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889811B1 (fr) * 2005-08-19 2009-10-09 Sanofi Aventis Sa Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
WO2010045190A1 (en) 2008-10-15 2010-04-22 Boehringer Ingelheim International Gmbh Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
EP2340243B1 (en) 2008-10-17 2014-10-08 Boehringer Ingelheim International GmbH Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
CN102018681A (zh) * 2010-12-10 2011-04-20 荣港生技医药科技(北京)有限公司 一种美乐托宁缓释剂、其制备方法及其应用
US20130060052A1 (en) * 2011-01-17 2013-03-07 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CA2903394C (en) 2013-03-14 2021-08-31 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US9120757B2 (en) 2013-03-14 2015-09-01 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
JP7792730B2 (ja) * 2022-04-27 2025-12-26 杭州新元素▲薬▼▲業▼有限公司 尿酸を降下させるために使用できる化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726447B2 (en) * 1996-10-21 2000-11-09 Neurosearch A/S 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulators
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
IL152411A0 (en) * 2000-04-24 2003-05-29 Teva Pharma Zolpidem hemitartrate
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a

Similar Documents

Publication Publication Date Title
AU2014219855B2 (en) Trk-inhibiting compound
JP6511430B2 (ja) がんの治療のための化合物および組成物
JP5387997B2 (ja) 血管の収縮または拡張による疾患治療剤
BR112017016193B1 (pt) Derivados de 4h-pirrolo[3,2-c]piridin-4-ona
JP2011509309A5 (cg-RX-API-DMAC7.html)
EP1988898A2 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
JP2003063994A (ja) アルツハイマー病およびパーキンソン病に関連する痴呆または認識障害のための組合せ治療
SK15432002A3 (sk) 2-acylindolové deriváty a ich použitie ako protinádorového prípravku
CN105120868A (zh) 组合治疗
US20050182089A1 (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
US7618650B2 (en) Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
RU2012130929A (ru) Гетероциклические соединения в качестве ингибиторов янус-киназы
WO2005070428A1 (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
JP2008543782A (ja) 5−ht1a受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト
US8716292B2 (en) Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
JP2008255064A (ja) 睡眠障害予防治療剤
US20240109850A1 (en) Covalent PPARG inverse-agonists
JP4555685B2 (ja) 肥満およびcns障害の処置のための選択的d1/d5レセプターアンタゴニスト
CN1867333A (zh) 含单胺神经递质再摄取抑制剂和乙酰胆碱酯酶抑制剂的药物组合物
KR20260022307A (ko) Trek(twik 관련 k+ 채널) 채널 기능의 억제제
ES2262515T3 (es) R-hidroxinefazodona.
EP4326269A1 (en) Compounds with improved cardiac safety for the treatment of cancer and neurodegenerative disorders
EP4387973A1 (en) Quinazoline-thiohydantoin fused heterocycles which are suitable for treating, ameliorating or preventing a proliferative disorder
JP2006501244A5 (cg-RX-API-DMAC7.html)
JP2009504760A (ja) 催眠剤及びR(+)−α−(2,3−ジメトキシ−フェニル)−1−[2−(4−フルオロフェニル)エチル]−4−ピペリジンメタノールの組み合わせ物並びに治療でのその使用